Identification and validation of Slit3 as a depression biomarker modulating dynorphinergic neurons in the hypothalamic paraventricular nucleus
- 12 November 2025
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 283, 110765
Abstract
No abstract availableKeywords
Funding Information
- Zhejiang Chinese Medical University (2022FSYYZZ11)
- National Natural Science Foundation of China (82030112)
- Medical Science and Technology Project of Zhejiang Province (2025KY985)
This publication has 60 references indexed in Scilit:
- Neurobiological basis of stress resilienceNeuron, 2024
- Contribution of inwardly rectifying K+ channel 4.1 of supraoptic astrocytes to the regulation of vasopressin neuronal activity by hypotonicityGlia, 2022
- ERK1/2-dependent BDNF synthesis and signaling is required for the antidepressant effect of microglia stimulationBrain, Behavior, and Immunity, 2022
- Amygdalar κ-opioid receptor-dependent upregulating glutamate transporter 1 mediates depressive-like behaviors of opioid abstinenceCell Reports, 2021
- PSD-93 up-regulates the synaptic activity of corticotropin-releasing hormone neurons in the paraventricular nucleus in depressionActa Neuropathologica, 2021
- The Bidirectional Relationship of Depression and Inflammation: Double TroubleNeuron, 2020
- Tissue-specific angiogenic and invasive properties of human neonatal thymus and bone MSCs: Role of SLIT3-ROBO1Stem Cells Translational Medicine, 2020
- The human hypothalamus in mood disorders: The HPA axis in the centerIBRO Reports, 2019
- The neurobiology of depression: An integrated viewAsian Journal of Psychiatry, 2017
- TNF-α-induced depressive-like phenotype and p38MAPK activation are abolished by ascorbic acid treatmentEuropean Neuropsychopharmacology, 2015